99 related articles for article (PubMed ID: 7754478)
1. [Neurotensin receptor antagonists and therapeutical perspectives].
Gully D; Maffrand JP; Soubrié P; Rostène W; Kitabgi P; Le Fur G
Therapie; 1995; 50(1):5-7. PubMed ID: 7754478
[TBL] [Abstract][Full Text] [Related]
2. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2.
Yamada M; Ohata H; Momose K; Yamada M; Richelson E
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):37-47. PubMed ID: 8581347
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
Santucci V; Gueudet C; Steinberg R; Le Fur G; Soubrié P
Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
[TBL] [Abstract][Full Text] [Related]
5. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists.
Azzi M; Gully D; Heaulme M; Bérod A; Pélaprat D; Kitabgi P; Boigegrain R; Maffrand JP; LeFur G; Rostène W
Eur J Pharmacol; 1994 Apr; 255(1-3):167-74. PubMed ID: 8026542
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692.
Herzig MC; Chapman WG; Sheridan A; Rake JB; Woynarowski JM
Anticancer Res; 1999; 19(1A):213-9. PubMed ID: 10226545
[TBL] [Abstract][Full Text] [Related]
10. Effect of the nonpeptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea pig ileum and colon.
Labbé-Jullié C; Deschaintres S; Gully D; Le Fur G; Kitabgi P
J Pharmacol Exp Ther; 1994 Oct; 271(1):267-76. PubMed ID: 7965724
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE
Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor.
Chen L; Yung KK; Yung WH
Neuroscience; 2004; 125(4):853-9. PubMed ID: 15120846
[TBL] [Abstract][Full Text] [Related]
13. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
14. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
15. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
[TBL] [Abstract][Full Text] [Related]
16. Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor.
Botto JM; Guillemare E; Vincent JP; Mazella J
Neurosci Lett; 1997 Feb; 223(3):193-6. PubMed ID: 9080465
[TBL] [Abstract][Full Text] [Related]
17. In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.
Croci T; Aureggi G; Guagnini F; Manara L; Gully D; Fur GL; Maffrand JP; Mukenge S; Ferla G; Ferrara P; Chalon P; Vita N
Br J Pharmacol; 1999 Aug; 127(8):1922-8. PubMed ID: 10482925
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin decreases high affinity [3H]-ouabain binding to cerebral cortex membranes.
Rosin C; Ordieres MG; Arnaiz GR
Regul Pept; 2011 Dec; 172(1-3):35-40. PubMed ID: 21896291
[TBL] [Abstract][Full Text] [Related]
19. The neurotensin receptor antagonist SR 48692 decreases extracellular striatal GABA in rats.
Chapman MA; See RE
Brain Res; 1996 Aug; 729(1):124-6. PubMed ID: 8874884
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization.
Hermans E; Octave JN; Maloteaux JM
Mol Pharmacol; 1996 Feb; 49(2):365-72. PubMed ID: 8632771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
